FON-2021-0568 IFG.pdf (393.63 kB)
Infographic: Isatuximab for relapsed/refractory multiple myeloma: review of key subgroup analyses from the phase 3 ICARIA-MM study
figure
posted on 2021-09-15, 08:37 authored by Paul G. Richardson, Simon J. Harrison, Sara Bringhen, Fredrik Schjesvold, Kwee Yong, Frank Campana, Solenn Le-Guennec, Sandrine Mac, Meletios A. DimopoulosInfographic – Summary of the Phase 3 ICARIA-MM study key subgroup analyses review
